Changda Liu1, David Dunkin, Joanne Lai, Ying Song, Clare Ceballos, Keith Benkov, Xiu-Min Li. 1. *Department of Pediatrics, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, New York; †Division of Gastroenterology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York; and ‡The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Abstract
BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Current medications have potentially serious side effects. Hence, there is increasing interest in alternative therapies. We previously demonstrated the anti-inflammatory effects of Food Allergy Herbal Formula-2 in vitro on peripheral blood mononuclear cells (PBMCs) and mucosa from CD subjects. Here, we investigated the anti-inflammatory effects of a bioactive compound isolated from Ganoderma lucidum (G. lucidum), a key herbal constituent of Food Allergy Herbal Formula-2, in CD in vitro. METHODS: Triterpene ganoderic acid C1 (GAC1) was isolated from G. lucidum. Stimulated RAW 264.7 macrophages were treated with GAC1. Human PBMCs and colonic biopsies were obtained from children with CD and cultured with or without GAC1. TNF-α and other proinflammatory cytokine levels were measured in the culture supernatant. NF-κB signaling was investigated in PBMCs and colonic mucosa treated with GAC1 by In-Cell Western and Western blot analysis. RESULTS: GAC1 decreased TNF-α production by macrophages and PBMCs from CD subjects. GAC1 significantly decreased TNF-α, IFN-γ, and IL-17A production by inflamed colonic biopsies from CD subjects. These effects were due to downregulation of the NF-κB signaling pathway. CONCLUSIONS: GAC1 inhibited production of TNF-α and other proinflammatory cytokines by PBMCs and inflamed CD colonic mucosa due to blockage of NF-κB activation. GAC1 is a key beneficial constituent in G. lucidum and the Food Allergy Herbal Formula-2 in suppressing the inflammatory cytokines found in CD and warrants clinical investigation for the treatment of CD.
BACKGROUND:Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Current medications have potentially serious side effects. Hence, there is increasing interest in alternative therapies. We previously demonstrated the anti-inflammatory effects of Food Allergy Herbal Formula-2 in vitro on peripheral blood mononuclear cells (PBMCs) and mucosa from CD subjects. Here, we investigated the anti-inflammatory effects of a bioactive compound isolated from Ganoderma lucidum (G. lucidum), a key herbal constituent of Food Allergy Herbal Formula-2, in CD in vitro. METHODS:Triterpeneganoderic acid C1 (GAC1) was isolated from G. lucidum. Stimulated RAW 264.7 macrophages were treated with GAC1. Human PBMCs and colonic biopsies were obtained from children with CD and cultured with or without GAC1. TNF-α and other proinflammatory cytokine levels were measured in the culture supernatant. NF-κB signaling was investigated in PBMCs and colonic mucosa treated with GAC1 by In-Cell Western and Western blot analysis. RESULTS:GAC1 decreased TNF-α production by macrophages and PBMCs from CD subjects. GAC1 significantly decreased TNF-α, IFN-γ, and IL-17A production by inflamed colonic biopsies from CD subjects. These effects were due to downregulation of the NF-κB signaling pathway. CONCLUSIONS:GAC1 inhibited production of TNF-α and other proinflammatory cytokines by PBMCs and inflamed CD colonic mucosa due to blockage of NF-κB activation. GAC1 is a key beneficial constituent in G. lucidum and the Food Allergy Herbal Formula-2 in suppressing the inflammatory cytokines found in CD and warrants clinical investigation for the treatment of CD.
Authors: Julie Wang; Sangita P Patil; Nan Yang; Jimmy Ko; Joohee Lee; Sally Noone; Hugh A Sampson; Xiu-Min Li Journal: Ann Allergy Asthma Immunol Date: 2010-07 Impact factor: 6.347
Authors: Tengfei Zhang; Kamal Srivastava; Ming-Chun Wen; Nan Yang; Jing Cao; Paula Busse; Neil Birmingham; Joseph Goldfarb; Xiu-Min Li Journal: Phytother Res Date: 2010-07 Impact factor: 5.878
Authors: Marc E Schaefer; Jason T Machan; David Kawatu; Christine R Langton; James Markowitz; Wallace Crandall; David R Mack; Jonathan S Evans; Marian D Pfefferkorn; Anne M Griffiths; Anthony R Otley; Athos Bousvaros; Subra Kugathasan; Joel R Rosh; David J Keljo; Ryan S Carvalho; Gitit Tomer; Petar Mamula; Marsha H Kay; Benny Kerzner; Maria Oliva-Hemker; Michael D Kappelman; Shehzad A Saeed; Jeffrey S Hyams; Neal S Leleiko Journal: Clin Gastroenterol Hepatol Date: 2010-05-31 Impact factor: 11.382
Authors: Edmund K Li; Lai-Shan Tam; Chun Kwok Wong; Wai Ching Li; Christopher W K Lam; Sissi Wachtel-Galor; Iris F F Benzie; Yi Xi Bao; Ping Chung Leung; Brian Tomlinson Journal: Arthritis Rheum Date: 2007-10-15
Authors: Kristin Kelly-Pieper; Sangita P Patil; Paula Busse; Nan Yang; Hugh Sampson; Xiu-Min Li; Juan P Wisnivesky; Meyer Kattan Journal: J Altern Complement Med Date: 2009-07 Impact factor: 2.579
Authors: K D Srivastava; Y Song; N Yang; C Liu; I E Goldberg; A Nowak-Węgrzyn; H A Sampson; X-M Li Journal: Clin Exp Allergy Date: 2017-05-15 Impact factor: 5.018
Authors: Schilin D Wen; Eulàlia Sans-Serramitjana; Javiera F Santander; Mariela R Sánchez; Paulina Salazar-Aguilar; Andrea B Zepeda; Susana I Alvarado; Ignacia B Miranda Journal: J Clin Exp Dent Date: 2021-10-01